{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T10:07:26Z","timestamp":1657015646118},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1006\/phrs.2000.0677","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T20:38:41Z","timestamp":1032381521000},"page":"151-156","source":"Crossref","is-referenced-by-count":1,"title":["Sequence-dependent toxicity profile in modified famtx (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: a feasibility study"],"prefix":"10.1006","volume":"42","author":[{"given":"A.M.","family":"Westermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.G.","family":"Taal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Boot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Craanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.R.","family":"Gerritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/phrs.2000.0677_RF1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/bjs.1800790404","article-title":"Improving survival in gastric cancer: Review of 5-year survival rates in English language publications from 1970","volume":"79","author":"Akoh","year":"1992","journal-title":"Br J Surg"},{"key":"10.1006\/phrs.2000.0677_RF2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.1990.8.8.1362","article-title":"A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group","volume":"8","author":"Coombes","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(94)92464-3","article-title":"The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up","volume":"343","author":"Hallissey","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/phrs.2000.0677_RF4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1200\/JCO.1993.11.8.1441","article-title":"Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials","volume":"11","author":"Hermans","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1200\/JCO.1994.12.5.970","article-title":"Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer","volume":"12","author":"Sautner","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF6","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1200\/JCO.1996.14.6.1818","article-title":"Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil","volume":"14","author":"Kelsen","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF7","first-page":"1175","article-title":"Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors","volume":"81","author":"Ochiai","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1006\/phrs.2000.0677_RF8","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1002\/1097-0142(19931101)72:9<2537::AID-CNCR2820720905>3.0.CO;2-5","article-title":"High-dose chemotherapy with autologous bone marrow transplantation in the treatment of advanced gastric cancer","volume":"72","author":"Suzuki","year":"1993","journal-title":"Cancer"},{"key":"10.1006\/phrs.2000.0677_RF9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P","article-title":"Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer","volume":"72","author":"Murad","year":"1993","journal-title":"Cancer"},{"key":"10.1006\/phrs.2000.0677_RF10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1008243606668","article-title":"Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer","volume":"8","author":"Glimelius","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1006\/phrs.2000.0677_RF11","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1055\/s-2008-1070192","article-title":"Chemotherapeutic protocol in the treatment of metastasising gastric carcinoma: methotrexate, adriamycin and 5-fluorouracil [German]","volume":"107","author":"Klein","year":"1982","journal-title":"Dtsch Med Wochschr"},{"key":"10.1006\/phrs.2000.0677_RF12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1991.9.5.827","article-title":"Sequential high-dose methotrexate and fluorouracil combined with doxorubicin\u2014a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group","volume":"5","author":"Wils","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1200\/JCO.1992.10.4.541","article-title":"FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer","volume":"10","author":"Kelsen","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0959-8049(97)86090-X","article-title":"Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophago-gastric cancer","volume":"15","author":"Webb","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF15","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1200\/JCO.1997.15.11.3313","article-title":"Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leukovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer","volume":"15","author":"Cascinu","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/phrs.2000.0677_RF16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.bjc.6690350","article-title":"Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial","volume":"80","author":"Waters","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1006\/phrs.2000.0677_RF17","first-page":"327","article-title":"Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil","volume":"37","author":"Bertino","year":"1977","journal-title":"Cancer Res"},{"key":"10.1006\/phrs.2000.0677_RF18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1126\/science.472732","article-title":"Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism","volume":"205","author":"Cadman","year":"1979","journal-title":"Science"},{"key":"10.1006\/phrs.2000.0677_RF19","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/0277-5379(90)90178-V","article-title":"5-Fluorouracil plus tauromustine in advanced colorectal cancer: unexpected negative results","volume":"26","author":"Taal","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1006\/phrs.2000.0677_RF20","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/0959-8049(93)90560-3","article-title":"Tauromustine (TCNU) combined with 5-fluorouracil and leukovorin in the treatment of advanced colon cancer","volume":"29A","author":"Taal","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1006\/phrs.2000.0677_RF21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00003088-199937030-00002","article-title":"Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer","volume":"37","author":"Danesi","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1006\/phrs.2000.0677_RF22","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1200\/JCO.1996.14.10.2713","article-title":"Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer","volume":"14","author":"Holmes","year":"1996","journal-title":"J Clin Oncol"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661800906777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661800906777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T04:50:58Z","timestamp":1557377458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661800906777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S1043661800906777"],"URL":"https:\/\/doi.org\/10.1006\/phrs.2000.0677","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}